Since TYMP plays an important role in platelet activation, thrombosis, and inflammation, and inhibition of TYMP with TPI significantly inhibited thrombosis in mice without causing bleeding, our study suggests that targeting TYMP with TPI could be a novel regimen for reducing COVID-19-associated thrombotic risk and inflammation. This evidence concerns the gene TYMP and COVID-19.